KEYNOTE-146: Lenvatinib Plus Pembrolizumab as Early-Line Treatment of Advanced Endometrial Cancer

Drs Ritu Salani and Eva Y. Pan discuss optimal approaches to current treatment of patients with gynecologic cancers in this module from Clinical Care Options (CCO)

Eva Y. Pan, PharmD, BCOP Ritu Salani, MD, MBA Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: May 13, 2022 Expired: May 12, 2023

Drs Ritu Salani and Eva Y. Pan discuss optimal approaches to current treatment of patients with gynecologic cancers in this module from Clinical Care Options (CCO)

Eva Y. Pan, PharmD, BCOP Ritu Salani, MD, MBA Released: May 13, 2022

Commentary on immunotherapy in endometrial cancer with a focus on older patients, from Clinical Care Options (CCO)

Domenica Lorusso, MD, PhD Released: April 29, 2022

Clinical commentary with Eloise Chapman-Davis, MD, FACOG, on healthcare equity in gynecologic cancers, from Clinical Care Options (CCO)

Eloise Chapman-Davis, MD, FACOG Released: March 1, 2022